In recent decades, advances in the treatment of patients with type 1 diabetes have made it possible to optimize metabolic control and reduce the frequency of safety events including hypoglycemia. Technology plays a fundamental role in the glycemic control of these patients and is increasingly used in the world diabetic population. However, changes in lifestyle continue to play a leading role and exercise is considered essential for managing not only diabetes but also associated comorbidities. The present review seeks to reinforce the knowledge from the physiological bases of this dichotomous and strong relationship between physical activity and type 1 diabetes and lay the therapeutic bases focused on the reduction of safety events, mainly hypoglycemia.
Colberg SR, Sigal RJ, Yardley JE, et al. Physical activity/exercise and diabetes: A position statement of the american diabetes association. Diabetes care. 2016;39(11):2065-2079. https://search.datacite.org/works/10.2337/dc16-1728. doi: 10.2337/dc16-1728.
Camacho RC, Galassetti P, Davis SN, Wasserman DH. Glucoregulation during and after exercise in health and insulin-dependent diabetes. Exercise and sport sciences reviews. 2005;33(1):17-23. https://www.ncbi.nlm.nih.gov/pubmed/15640716.
Riddell MC, Gallen IW, Smart CE, et al. Exercise management in type 1 diabetes: A consensus statement. The lancet. Diabetes & endocrinology. 2017;5(5):377-390. https://search.datacite.org/works/10.1016/s2fig213-8587(17)30014-1. doi: 10.1016/S2213-8587(17)30014-1.
Bally L, Laimer M, Stettler C. Exercise-associated glucose metabolism in individuals with type 1 diabetes mellitus. Current opinion in clinical nutrition and metabolic care. 2015;18(4):428-433. https://search.datacite.org/works/10.1097/mco.0000000000000185. doi: 10.1097/mco.0000000000000185.
Mallad A, Hinshaw L, Schiavon M, et al. Exercise effects on postprandial glucose metabolism in type 1 diabetes: a triple-tracer approach. Am J Physiol Endocrinol Metab. 2015;308(12):E1106-E1115. doi:10.1152/ajpendo.00014.2015
Harmer AR, Chisholm DJ, McKenna MJ, et al. Sprint training increases muscle oxidative metabolism during high-intensity exercise in patients with type 1 diabetes. Diabetes care. 2008;31(11):2097-2102. https://search.datacite.org/works/10.2337/dc08-0329. doi: 10.2337/dc08-0329.
Turner D, Luzio S, Gray BJ, et al. Impact of single and multiple sets of resistance exercise in type 1 diabetes. Scandinavian journal of medicine & science in sports. 2015;25(1):e99-e109. https://search.datacite.org/works/10.1111/sms.12202. doi: 10.1111/sms.12202.
McMahon SK, Ferreira LD, Ratnam N, Davey RJ, Youngs LM, Davis EA, Fournier PA, Jones TW. Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with type 1 diabetes are increased in a biphasic manner. J Clin Endocrinol Metab. 2007;92(3):963–8.
Brazeau AS, Rabasa-Lhoret R, Strychar I, Mircescu H. Barriers to physical activity among patients with type 1 diabetes. Diabetes Care. 2008;31(11):2108–9.
Warburton, D. E. R., Jamnik, V., Bredin, S. S. D., Shephard, R. J., & Gledhill, N. (2018). The 2018 Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) and electronic Physical Activity Readiness Medical Examination (ePARmed-X+): 2018 PAR-Q+. The Health & Fitness Journal of Canada, 11(1), 31-34. https://doi.org/10.14288/hfjc.v11i1.260)
Adolfsson P, Mattsson S, Jendle J. Evaluation of glucose control when a new strategy of increased carbohydrate supply is implemented during prolonged physical exercise in type 1 diabetes. Eur J Appl Physiol 2015; 115: 2599–607.
Campbell MD, Walker M, Trenell MI, et al. A low-glycemic index meal and bedtime snack prevents postprandial hyperglycemia and associated rises in inflammatory markers, providing protection from early but not late nocturnal hypoglycemia following evening exercise in type 1 diabetes. Diabetes Care 2014; 37: 1845–53.
Hernandez JM, Moccia T, Fluckey JD, Ulbrecht JS, Farrell PA. Fluid snacks to help persons with type 1 diabetes avoid late onset postexercise hypoglycemia. Med Sci Sports Exerc 2000; 32: 904–10.
Bracken RM, West DJ, Stephens JW, Kilduff LP, Luzio S, Bain SC. Impact of pre-exercise rapid-acting insulin reductions on ketogenesis following running in type 1 diabetes. Diabet Med 2011; 28: 218–22.
Arutchelvam V, Heise T, Dellweg S, Elbroend B, Minns I,Home PD. Plasma glucose and hypoglycaemia following exercise in people with type 1 diabetes: a comparison of three basal insulins. Diabet Med 2009; 26: 1027–32.
Thabit H, Hovorka R. The future of the artificial pancreas. Diabetes technology & therapeutics. 2015;17(11):763-765. https://www.liebertpub.com/doi/abs/10.1089/dia.2015.0297. doi: 10.1089/dia.2015.0297.
Gandhi GY, Kovalaske M, Kudva Y, Walsh K, Elamin MB, Beers M, et al. Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta- analysis of randomized trials. J Diabetes Sci Technol. (2011) 5:952–65. doi: 10.1177/193229681100500419
Riddell MC, Milliken J. Preventing exercise-induced hypoglycemia in type 1 diabetes using real-time continuous glucose monitoring and a new carbohydrate intake algorithm: an observational field study. Diabetes Technol Ther. (2011) 13:819–25. doi: 10.1089/dia.2011.0052.
Breton MD, Patek SD, Lv D, Schertz E, Robic J, Pinnata J, et al. Continuous glucose monitoring and insulin informed advisory system with automated titration and dosing of insulin reduces glucose variability in type 1 diabetes mellitus. Diabetes Technol Ther. (2018) 20:531–40. doi: 10.1089/dia.2018.0079.
Radermecker R-P, Fayolle C, Brun J-F, Bringer J, Renard E. Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion. Diabetes Metab. (2013) 39:258–62. doi: 10.1016/j.diabet.2012.12.004.
Tagougui S, Taleb N and Rabasa-Lhoret R (2019) The Benefits and Limits of Technological Advances in Glucose Management Around Physical Activity in Patients Type 1 Diabetes. Front. Endocrinol. 9:818. doi: 10.3389/fendo.2018.00818.
Lenhard MJ, Reeves GD. Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med. (2001) 161:2293–300. doi: 10.1001/archinte.161.19.2293.
Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care (2002) 25:593–8. doi: 10.2337/diacare.25.3.593.
Franc S, Daoudi A, Pochat A, Petit M-H, Randazzo C, Petit C, et al. Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study. Diabetes Obes Metab. (2015) 17:1150–57. doi: 10.1111/dom.12552.
Zaharieva D, Yavelberg L, Jamnik V, Cinar A, Turksoy K, Riddell MC. The effects of basal insulin suspension at the start of exercise on blood glucose levels during continuous versus circuit-based exercise in individuals with type 1 diabetes on continuous subcutaneous insulin infusion. Diabetes Technol Ther. (2017) 19:370–8. doi: 10.1089/dia.2017.0010.
Admon G, Weinstein Y, Falk B, Weintrob N, Benzaquen H, Ofan R, et al. Exercise with and without an insulin pump among children and adolescents with type 1 diabetes mellitus. Pediatrics (2005) 116:e348–55. doi: 10.1542/peds.2004-2428.
Diabetes Research in Children Network (DirecNet) Study Group, Tsalikian E, Kollman C, Tamborlane WB, Beck RW, Fiallo-Scharer R, et al. Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care (2006) 29:2200–4. doi: 10.2337/dc06-0495
Taplin CE, Cobry E, Messer L, McFann K, Chase HP, Fiallo-Scharer R. Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes. J Pediatr. (2010) 157:784–8.e1. doi: 10.1016/j.jpeds.2010.06.004.
Food and Drug Administration, Center for Devices and Radiological Health: MiniMed 670G System approval letter, September 28, 2016. Available at: https://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm522974.htm Accessed May 19, 2018.
Cohen O, Vigersky RA, Lee SW, Cordero TL, Kaufman FR. Automated insulin delivery system nomenclature. Diabetes technology & therapeutics. 2017;19(6):379-380. https://www.liebertpub.com/doi/abs/10.1089/dia.2017.0073. doi: 10.1089/dia.2017.0073.
Aleppo G, Webb KM. Integrated insulin pump and continuous glucose monitoring technology in diabetes care today: A perspective of real-life experience with the minimed™ 670g hybrid closed-loop system. Endocrine practice. 2018;24(7):684-692. https://www.ncbi.nlm.nih.gov/pubmed/30048171. doi: 10.4158/EP-2018-0097.
Garg SK, Weinzimer SA, Tamborlane WV, et al. Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes technology & therapeutics. 2017;19(3):155-163. https://search.datacite.org/works/10.1089/dia.2016.0421. doi: 10.1089/dia.2016.0421.
Gomez AM, Gomez C, Aschner P, et al. Effects of performing morning versus afternoon exercise on glycemic control and hypoglycemia frequency in type 1 diabetes patients on sensor-augmented insulin pump therapy. Journal of diabetes science and technology. 2015;9(3):619-624. https://search.datacite.org/works/10.1177/1932296814566233. doi: 10.1177/1932296814566233.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2022 Revista Colombiana de Endocrinología, Diabetes & Metabolismo